CME Group (NASDAQ: CME) reported Q3 EPS of $1.45, in-line with the analyst estimate of $1.45. Revenue for the quarter came in at $904 million versus the consensus estimate of $927.32 million.

"The third quarter improved steadily from July to September, driven by strength in our interest rate, equities and metals product lines," said CME Group Chairman and Chief Executive Officer Terry Duffy. "Our solid expense management contributed to adjusted diluted earnings per share growth of more than 20 percent in the third quarter. Open interest has continued to rise to more than 128 million contracts, which illustrates the growing need for risk management globally. In addition, we have had an exceptional start to the fourth quarter, with growth in all six product areas and total volume up more than 40 percent compared with the same period a year ago."

For earnings history and earnings-related data on CME Group (CME) click here.